Impact of pegylated interferon alfa-2B and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C: Thierry Poynard, Hepatologie Groupe Hospitalier Pitie Salpetriere, Paris France; John McHutchinson, Scripps Clinic and Research Foundation, Division of Gastroenterology/Hepatology, La Jolla, CA; Michael Manns, Division of Gastroenterology and Hepatology, Medical School of Hanover, Hannover Germany; Christian Trepo,: Service d'Hépato-Gastrointestinal and Liver Disease, University of Southern California, Los Angeles, CA; Zachary Goodman, Department of Hepatic and Gastrointestinal Pathology, Armed Forces Institute of Pathology, Washington, DC; Mei-Shu Ling, Janice K Albrecht, Schering Plough Research Institute, Kennilworth, NJ